Viewing Study NCT01870895

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:36 PM
Ignite Modification Date: 2026-05-09 @ 4:53 AM
Study NCT ID: NCT01870895
Status: COMPLETED
Last Update Posted: 2015-10-12
First Post: 2013-06-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS)
Sponsor: Astellas Pharma Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diarrhea-predominant Irritable Bowel Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None YM060 View
None Ramosetron View
None Diarrhea-predominant Irritable Bowel Syndrome View